Novartis (NVS) News Today $120.93 -2.80 (-2.26%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$123.24 +2.32 (+1.91%) As of 07/11/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Why Novartis Is Still A 'Buy' After 15% SurgeJuly 13 at 11:01 AM | seekingalpha.comNovartis AG (NYSE:NVS) Shares Acquired by Ballentine Partners LLCJuly 13 at 5:23 AM | marketbeat.comStratos Wealth Partners LTD. Has $1.12 Million Stock Position in Novartis AG (NYSE:NVS)July 13 at 4:00 AM | marketbeat.comKathmere Capital Management LLC Has $2.09 Million Stock Position in Novartis AG (NYSE:NVS)July 12 at 8:28 AM | marketbeat.comRiversedge Advisors LLC Takes $264,000 Position in Novartis AG (NYSE:NVS)July 12 at 7:20 AM | marketbeat.comCerity Partners LLC Grows Stock Holdings in Novartis AG (NYSE:NVS)July 12 at 5:38 AM | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Bank of New York Mellon CorpJuly 12 at 4:12 AM | marketbeat.comNovartis loses bid to block US Entresto generic through 2026July 11 at 12:27 PM | reuters.comNovartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS)July 11 at 11:26 AM | theglobeandmail.comHead to Head Survey: Novartis (NYSE:NVS) vs. Eli Lilly and Company (NYSE:LLY)July 11 at 2:31 AM | americanbankingnews.comNovartis (NYSE:NVS) Reaches New 1-Year High - Still a Buy?July 10, 2025 | marketbeat.comParr Mcknight Wealth Management Group LLC Buys 3,149 Shares of Novartis AG (NYSE:NVS)July 10, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Brown Advisory Inc.July 10, 2025 | marketbeat.comNovartis (NVS) to Release Quarterly Earnings on ThursdayJuly 10, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $179.33 Million Stock Position in Novartis AG (NYSE:NVS)July 9, 2025 | marketbeat.comNovartis wins approval for first malaria drug for newborns and babiesJuly 8, 2025 | msn.comNovartis wins approval for first malaria drug for newbornsJuly 8, 2025 | ft.comNovartis wins Swiss approval for Coartem Baby, first malaria drug for infants and young childrenJuly 8, 2025 | msn.comNovartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young InfantsJuly 8, 2025 | msn.comCapital Advisors Inc. OK Buys Shares of 2,066 Novartis AG (NYSE:NVS)July 8, 2025 | marketbeat.comNovartis gets approval for first malaria drug for babies and childrenJuly 8, 2025 | reuters.comNovartis receives approval for first malaria medicine for newborn babies and young infantsJuly 8, 2025 | globenewswire.comJ Hagan Capital Inc. Makes New $336,000 Investment in Novartis AG (NYSE:NVS)July 7, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Bought by Financial Counselors Inc.July 7, 2025 | marketbeat.comCallan Capital LLC Acquires 5,366 Shares of Novartis AG (NYSE:NVS)July 7, 2025 | marketbeat.comNovartis (NYSE:NVS) vs. Roche (OTCMKTS:RHHBY) Head to Head AnalysisJuly 7, 2025 | americanbankingnews.comDeutsche Bank Reaffirms Their Buy Rating on Novartis AG (NOVN)July 6, 2025 | theglobeandmail.comWorld Investment Advisors Raises Holdings in Novartis AG (NYSE:NVS)July 6, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Given Consensus Recommendation of "Hold" by BrokeragesJuly 6, 2025 | marketbeat.comCatalyst Capital Advisors LLC Increases Holdings in Novartis AG (NYSE:NVS)July 4, 2025 | marketbeat.comTimber Creek Capital Management LLC Sells 5,799 Shares of Novartis AG (NYSE:NVS)July 4, 2025 | marketbeat.comDavidson Trust Co. Sells 5,771 Shares of Novartis AG (NYSE:NVS)July 4, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Principal Financial Group Inc.July 4, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Purchases 14,057 Shares of Novartis AG (NYSE:NVS)July 4, 2025 | marketbeat.comNovartis fails in late-stage trial for Cosentyx in giant cell arteritisJuly 3, 2025 | msn.comNovartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns BullishJuly 3, 2025 | msn.comD.A. Davidson & CO. Sells 65,251 Shares of Novartis AG (NYSE:NVS)July 3, 2025 | marketbeat.comRossby Financial LCC Makes New $288,000 Investment in Novartis AG (NYSE:NVS)July 3, 2025 | marketbeat.comNovartis drug Cosentyx fails late-stage trial for artery diseaseJuly 3, 2025 | reuters.comNovartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)July 3, 2025 | prnewswire.comNovartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)July 3, 2025 | globenewswire.comUBS Sticks to Its Hold Rating for Novartis AG (NOVN)July 2, 2025 | theglobeandmail.comNovartis (NYSE:NVS) Sets New 52-Week High - Time to Buy?June 30, 2025 | marketbeat.comAltus Wealth Group LLC Purchases New Stake in Novartis AG (NYSE:NVS)June 30, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by First Fiduciary Investment Counsel Inc.June 30, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Stake Boosted by Joel Isaacson & Co. LLCJune 30, 2025 | marketbeat.com7 Killer European Stocks To Buy In JulyJune 29, 2025 | 247wallst.com4,702 Shares in Novartis AG (NYSE:NVS) Bought by Guerra Advisors IncJune 29, 2025 | marketbeat.comBSW Wealth Partners Has $401,000 Stock Holdings in Novartis AG (NYSE:NVS)June 29, 2025 | marketbeat.comNovartis (NVS) Acquires Regulus Therapeutics for $1.7 BillionJune 28, 2025 | insidermonkey.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼0.921.01▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼2617▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News SNY News GSK News TAK News ARGX News BNTX News ONC News TEVA News INSM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVS Stock Alerts